Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|Forty Seven, Inc. Announces Updated Data...||06/15/19|
|Forty Seven, Inc., a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, toda...|
|Date||2019-05-13 (BMO)||Est. (EPS/Rev.)||($0.63)/ 0|
|Actual (EPS/Rev.)||$-0.74/||EPS (TTM)||0|